Genrix (shanghai) Biopharmaceutical Co., Ltd.

This study is testing whether adding an experimental injection called GR1802 to standard allergy medications helps people with severe seasonal allergies feel better. It will involve 144 adults whose usual allergy treatments haven't worked well enough. Researchers will measure cha…

This is the first human study of an experimental injection called GR2301. Researchers will give single doses to 36 healthy adults in China to check for side effects and see how the body processes it. The study will follow participants for about 4 months to monitor their health an…